BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12635377)

  • 21. [Expression and significance of urokinase-type plasminogen activator, its receptor, and type 2 inhibitor in giant cell tumor of bone].
    Li H; Dong S; Zeng Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):386-8. PubMed ID: 11810768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giant cell tumour of talus with osteosarcomatous transformation in a young male: a case report.
    Agarwal K; Bajaj P; Aiyer HM; Sood LK
    Indian J Pathol Microbiol; 2003 Apr; 46(2):215-7. PubMed ID: 15022914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone giant cell tumour in neuropathological practice. A fifty year overview.
    Kujas M; Faillot T; Van Effenterre R; Poirier J
    Arch Anat Cytol Pathol; 1999; 47(1):7-12. PubMed ID: 10089677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Giant Cell Tumor (tumor gigantocellularis, osteoclastoma) - epidemiology, diagnosis, treatment.
    Karpik M
    Ortop Traumatol Rehabil; 2010; 12(3):207-15. PubMed ID: 20675862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multicentric giant cell tumour. The case report].
    Miszczyk L; Horzela A; Wozniak G; Spindel J; Owczarek G
    Przegl Lek; 2004; 61(12):1455-8. PubMed ID: 15850349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
    Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
    Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of the reactivity of giant cell tumors of bones to different lectins].
    Illés T; Dubousset J; Szendröi M
    Arch Anat Cytol Pathol; 1995; 43(5-6):331-7. PubMed ID: 8729849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone.
    Suzuki Y; Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Nakashima H; Ishiguro N
    Knee; 2007 Oct; 14(5):369-74. PubMed ID: 17601737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administration.
    Cheng YY; Huang L; Kumta SM; Lee KM; Lai FM; Tam JS
    Ultrastruct Pathol; 2003; 27(6):385-91. PubMed ID: 14660277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicentric giant cell tumor of bone--a case report and comprehensive review of literature.
    Taraporvala JC; Goyal DR; Hire D
    Indian J Cancer; 1997 Sep; 34(3):128-35. PubMed ID: 9491674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.
    Ladekarl M
    APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The comparative biochemical and morphological characteristics of chondrosarcoma and giant-cell tumor of the bone].
    Akbasheva OE; Shchepetkin IA; Vasil'ev NV; Zheravin AA; Anisenia II; Buél' EV; Zhukova IaA
    Vopr Onkol; 2000; 46(3):298-301. PubMed ID: 10976275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time required for effective action of phenol against giant cell tumour cells.
    Nithyananth M; Priscilla AJ; Boopalan PV; Titus VT; Lee VN
    J Orthop Surg (Hong Kong); 2014 Apr; 22(1):104-7. PubMed ID: 24781626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of digital cameras: features essential for the orthopaedic surgeon.
    Birkenmaier C
    Clin Orthop Relat Res; 2004 Nov; (428):308; author reply 309. PubMed ID: 15534557
    [No Abstract]   [Full Text] [Related]  

  • 36. Commentary: Time required for effective action of phenol against giant cell tumour cells.
    Waikakul S
    J Orthop Surg (Hong Kong); 2014 Apr; 22(1):3. PubMed ID: 24781603
    [No Abstract]   [Full Text] [Related]  

  • 37. A diagnostic approach to bone tumours.
    Flanagan AM; Lindsay D
    Pathology; 2017 Dec; 49(7):675-687. PubMed ID: 29110879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protocol for the study of bone tumours and standardization of pathology reports].
    Machado I; Pozo JJ; Marcilla D; Cruz J; Tardío JC; Astudillo A; Bagué S
    Rev Esp Patol; 2017; 50(1):34-44. PubMed ID: 29179963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiological Features of Giant Cell Tumours of Bone.
    Howard EL; Gregory J; Winn N; Flanagan A; Cool P
    Cureus; 2020 Jun; 12(6):e8793. PubMed ID: 32724742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological grading of primary bone tumors.
    McCarthy EF
    Skeletal Radiol; 2009 Oct; 38(10):947-8. PubMed ID: 19701747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.